Drug Shortage Report for LOSEC 10 MG
| Report ID | 67310 |
| Drug Identification Number | 02230737 |
| Brand name | LOSEC 10 MG |
| Common or Proper name | omeprazole magnesium delayed release tablets |
| Company Name | ASTRAZENECA CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | OMEPRAZOLE |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 2 x 15 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2018-12-14 |
| Actual start date | 2018-12-14 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2019-11-18 |
| Company comments | The product will be discontinued as of November 16, 2019. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.